Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.

MLA

Capozzi, Antonella, et al. “Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.” Molecules (Basel, Switzerland), vol. 27, no. 1, Dec. 2021. EBSCOhost, https://doi.org/10.3390/molecules27010064.

APA

Capozzi, A., Caissutti, D., Mattei, V., Gado, F., Martellucci, S., Longo, A., Recalchi, S., Manganelli, V., Riitano, G., Garofalo, T., Sorice, M., Manera, C., & Misasi, R. (2021). Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells. Molecules (Basel, Switzerland), 27(1). https://doi.org/10.3390/molecules27010064

Chicago

Capozzi, Antonella, Daniela Caissutti, Vincenzo Mattei, Francesca Gado, Stefano Martellucci, Agostina Longo, Serena Recalchi, et al. 2021. “Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.” Molecules (Basel, Switzerland) 27 (1). doi:10.3390/molecules27010064.